Risks and benefits of resumption of anticoagulation following traumatic brain injury remain complex and uncertain-reply.
University of Maryland School of Medicine, Baltimore.
Jennifer S
JS
Albrecht
Philips Healthcare, San Francisco, California.
Xinggang
X
Liu
IMPAQ International, LLC, Columbia, Maryland.
Ilene H
IH
Zuckerman
D000925:Anticoagulants / Q000009:adverse effects*; D001281:Atrial Fibrillation / Q000188:drug therapy*; D001930:Brain Injuries / Q000150:complications*; D005260:Female; D006470:Hemorrhage / Q000139:chemically induced*; D006801:Humans; D008297:Male; D018570:Risk Assessment; D013927:Thrombosis / Q000517:prevention & control*; D014859:Warfarin / Q000009:adverse effects*
D000925:Anticoagulants; D014859:Warfarin